May 23, 2018 Bill Thompson May 29, 2018 Class Action, Daily, Government, Health, Pharma, Products, Quality Fraud, Science, Statistics Comments Off on May 23, 2018 BMJ: United States’ FDA providing insufficient information on post-approval drug effectiveness.
